 | Up a level |
Connolly, Stuart J; Sharma, Mukul; Cohen, Alexander T; Demchuk, Andrew M; Członkowska, Anna; Lindgren, Arne G; Molina, Carlos A; Bereczki, Daniel; Toni, Danilo; Seiffge, David J; Tanne, David; Sandset, Else Charlotte; Tsivgoulis, Georgios; Christensen, Hanne; Beyer-Westendorf, Jan; Coutinho, Jonathan M; Crowther, Mark; Verhamme, Peter; Amarenco, Pierre; Roine, Risto O; ... (2024). Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage. The New England journal of medicine, 390(19), pp. 1745-1755. Massachusetts Medical Society 10.1056/NEJMoa2313040
Patel, Siddharth M; Braunwald, Eugene; Steffel, Jan; Boriani, Giuseppe; Palazzolo, Michael G; Antman, Elliott M; Bohula, Erin A; Carnicelli, Anthony P; Connolly, Stuart J; Eikelboom, John; Gencer, Baris; Granger, Christopher B; Morrow, David A; Patel, Manesh R; Wallentin, Lars; Ruff, Christian T; Giugliano, Robert P (2024). Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58 464 Patients With Atrial Fibrillation. Circulation, 149(12), pp. 932-943. American Heart Association 10.1161/CIRCULATIONAHA.123.066279
Benz, Alexander P; Hohnloser, Stefan H; Eikelboom, John W; Carnicelli, Anthony P; Giugliano, Robert P; Granger, Christopher B; Harrington, Josephine; Hijazi, Ziad; Morrow, David A; Patel, Manesh R; Seiffge, David J; Shoamanesh, Ashkan; Wallentin, Lars; Yi, Qilong; Connolly, Stuart J (2023). Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation. European Heart Journal, 44(20), pp. 1807-1814. Oxford University Press 10.1093/eurheartj/ehad200
